QQQ   358.05 (+0.85%)
AAPL   170.81 (+0.22%)
MSFT   313.40 (+0.20%)
META   304.05 (+2.12%)
GOOGL   132.08 (+1.18%)
AMZN   125.96 (-0.02%)
TSLA   245.92 (+2.25%)
NVDA   430.73 (+1.42%)
NIO   8.91 (+5.32%)
BABA   85.52 (-0.78%)
AMD   102.72 (+4.74%)
T   14.98 (+0.74%)
F   12.56 (+1.37%)
MU   65.43 (-4.08%)
CGC   0.81 (-8.54%)
GE   112.36 (+1.33%)
DIS   80.07 (+0.21%)
AMC   7.76 (+2.51%)
PFE   32.06 (-0.12%)
PYPL   58.14 (+1.40%)
NFLX   375.81 (-0.47%)
QQQ   358.05 (+0.85%)
AAPL   170.81 (+0.22%)
MSFT   313.40 (+0.20%)
META   304.05 (+2.12%)
GOOGL   132.08 (+1.18%)
AMZN   125.96 (-0.02%)
TSLA   245.92 (+2.25%)
NVDA   430.73 (+1.42%)
NIO   8.91 (+5.32%)
BABA   85.52 (-0.78%)
AMD   102.72 (+4.74%)
T   14.98 (+0.74%)
F   12.56 (+1.37%)
MU   65.43 (-4.08%)
CGC   0.81 (-8.54%)
GE   112.36 (+1.33%)
DIS   80.07 (+0.21%)
AMC   7.76 (+2.51%)
PFE   32.06 (-0.12%)
PYPL   58.14 (+1.40%)
NFLX   375.81 (-0.47%)
QQQ   358.05 (+0.85%)
AAPL   170.81 (+0.22%)
MSFT   313.40 (+0.20%)
META   304.05 (+2.12%)
GOOGL   132.08 (+1.18%)
AMZN   125.96 (-0.02%)
TSLA   245.92 (+2.25%)
NVDA   430.73 (+1.42%)
NIO   8.91 (+5.32%)
BABA   85.52 (-0.78%)
AMD   102.72 (+4.74%)
T   14.98 (+0.74%)
F   12.56 (+1.37%)
MU   65.43 (-4.08%)
CGC   0.81 (-8.54%)
GE   112.36 (+1.33%)
DIS   80.07 (+0.21%)
AMC   7.76 (+2.51%)
PFE   32.06 (-0.12%)
PYPL   58.14 (+1.40%)
NFLX   375.81 (-0.47%)
QQQ   358.05 (+0.85%)
AAPL   170.81 (+0.22%)
MSFT   313.40 (+0.20%)
META   304.05 (+2.12%)
GOOGL   132.08 (+1.18%)
AMZN   125.96 (-0.02%)
TSLA   245.92 (+2.25%)
NVDA   430.73 (+1.42%)
NIO   8.91 (+5.32%)
BABA   85.52 (-0.78%)
AMD   102.72 (+4.74%)
T   14.98 (+0.74%)
F   12.56 (+1.37%)
MU   65.43 (-4.08%)
CGC   0.81 (-8.54%)
GE   112.36 (+1.33%)
DIS   80.07 (+0.21%)
AMC   7.76 (+2.51%)
PFE   32.06 (-0.12%)
PYPL   58.14 (+1.40%)
NFLX   375.81 (-0.47%)
OTC:BBLG

Bone Biologics (BBLG) Stock Forecast, Price & News

$0.72
0.00 (0.00%)
(As of 09/27/2023 ET)
Compare
Today's Range
$0.70
$0.75
50-Day Range
$0.62
$1.45
52-Week Range
$0.57
$35.40
Volume
24,393 shs
Average Volume
157,802 shs
Market Capitalization
$2.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$67.50

Bone Biologics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
9,275.0% Upside
$67.50 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.13mentions of Bone Biologics in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($8.15) to ($10.63) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.69 out of 5 stars


BBLG stock logo

About Bone Biologics (OTC:BBLG) Stock

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

BBLG Price History

BBLG Stock News Headlines

Financial Survey: Bone Biologics (BBLG) versus Its Peers
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Bone Biologics (BBLG) & The Competition Head to Head Survey
Bone broth
Bone Biologics (BBLG) vs. The Competition Financial Comparison
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
BBLG Advances Crucial Technology and Solidifies Funding
BBLG - Bone Biologics Corporation
Bone Biologics Effects 1-for-30 Reverse Stock Split
BBLG: BBLG Has Solid Cash and Is Advancing Testing
S-1: Bone Biologics Corp
See More Headlines
Receive BBLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

BBLG Company Calendar

Today
9/28/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$67.50
High Stock Price Forecast
$67.50
Low Stock Price Forecast
$67.50
Forecasted Upside/Downside
+9,275.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-1,490,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.82 per share

Miscellaneous

Free Float
2,886,000
Market Cap
$2.26 million
Optionable
Not Optionable
Beta
0.21
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Jeffrey Frelick (Age 57)
    CEO & Pres
    Comp: $337.75k
  • Ms. Deina H. Walsh (Age 59)
    Chief Financial Officer
    Comp: $218.88k
  • Dr. Shun'ichi Kuroda
    Co-Founder & Member of Scientific Advisory Board













BBLG Stock - Frequently Asked Questions

Should I buy or sell Bone Biologics stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bone Biologics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BBLG shares.
View BBLG analyst ratings
or view top-rated stocks.

What is Bone Biologics' stock price forecast for 2023?

1 equities research analysts have issued 12 month price objectives for Bone Biologics' stock. Their BBLG share price forecasts range from $67.50 to $67.50. On average, they expect the company's stock price to reach $67.50 in the next twelve months. This suggests a possible upside of 9,275.0% from the stock's current price.
View analysts price targets for BBLG
or view top-rated stocks among Wall Street analysts.

How have BBLG shares performed in 2023?

Bone Biologics' stock was trading at $6.2910 at the start of the year. Since then, BBLG stock has decreased by 88.6% and is now trading at $0.72.
View the best growth stocks for 2023 here
.

When did Bone Biologics' stock split?

Bone Biologics's stock reverse split on Wednesday, June 7th 2023. The 1-30 reverse split was announced on Wednesday, June 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What is Bone Biologics' stock symbol?

Bone Biologics trades on the OTC under the ticker symbol "BBLG."

Who are Bone Biologics' major shareholders?

Bone Biologics' stock is owned by many different institutional and retail investors. Top institutional shareholders include Walleye Capital LLC (9.41%).

How do I buy shares of Bone Biologics?

Shares of BBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bone Biologics' stock price today?

One share of BBLG stock can currently be purchased for approximately $0.72.

How much money does Bone Biologics make?

Bone Biologics (OTC:BBLG) has a market capitalization of $2.26 million. The company earns $-1,490,000.00 in net income (profit) each year or ($9.20) on an earnings per share basis.

How can I contact Bone Biologics?

The official website for the company is www.bonebiologics.com. The company can be reached via phone at 781-552-4452 or via email at kgolodetz@lhai.com.

This page (OTC:BBLG) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -